A Morvan, M Gazon, S Duperret, Z Schmitt, P Pradat, K Mohkam, F Aubrun
{"title":"肝肺综合征和肝移植后并发症:一项病例对照研究。","authors":"A Morvan, M Gazon, S Duperret, Z Schmitt, P Pradat, K Mohkam, F Aubrun","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Although liver transplantation (LT) improves survival in cirrhotic patients with hepatopulmonary syndrome (HPS), few data exist concerning post-operative complications in these patients.</p><p><strong>Objective: </strong>To compare complications after LT between patients with and without HPS.</p><p><strong>Methods: </strong>In a case-control study, we retrospectively analyzed all patients who underwent LT in our center from January 2010 to July 2016. We compared cases of identified HPS to controls matched for age, MELD score, comorbidities, red blood cells transfused, and highest dosage of norepinephrine perfused during transplantation.</p><p><strong>Results: </strong>Among 451 transplanted patients, we identified 71 patients with HPS who could be analyzed. We found a significantly (p<0.001) higher number of post-operative complications in patients with HPS (median 5 <i>vs</i> 3), with more occurrence of cardiac, infectious and surgical complications than in the controls: 39.4% <i>vs</i> 12.7% (p<0.001), 81.7% <i>vs</i> 49.3% (p<0.001), and 59.2% <i>vs</i> 40.1% (p<0.029), respectively. There were also more ICU readmissions at 1 month among HPS patients (10 <i>vs</i> 1, p=0.01). There was no significant difference concerning ventilation data, lengths of ICU or hospital stay (8.5 [range 3-232] and 32 [14-276] days, respectively on the whole cohort) and death in the ICU (4.2% on the whole cohort). The 1-year survival was higher in HPS patients (94.4% <i>vs</i> 81.1%, p=0.034); there was no difference in 5-year survival.</p><p><strong>Conclusion: </strong>HPS patients seem to have a higher number of complications in the first month following LT.</p>","PeriodicalId":14242,"journal":{"name":"International Journal of Organ Transplantation Medicine","volume":"11 4","pages":"166-175"},"PeriodicalIF":0.3000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726840/pdf/ijotm-11-166.pdf","citationCount":"0","resultStr":"{\"title\":\"Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study.\",\"authors\":\"A Morvan, M Gazon, S Duperret, Z Schmitt, P Pradat, K Mohkam, F Aubrun\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Although liver transplantation (LT) improves survival in cirrhotic patients with hepatopulmonary syndrome (HPS), few data exist concerning post-operative complications in these patients.</p><p><strong>Objective: </strong>To compare complications after LT between patients with and without HPS.</p><p><strong>Methods: </strong>In a case-control study, we retrospectively analyzed all patients who underwent LT in our center from January 2010 to July 2016. We compared cases of identified HPS to controls matched for age, MELD score, comorbidities, red blood cells transfused, and highest dosage of norepinephrine perfused during transplantation.</p><p><strong>Results: </strong>Among 451 transplanted patients, we identified 71 patients with HPS who could be analyzed. We found a significantly (p<0.001) higher number of post-operative complications in patients with HPS (median 5 <i>vs</i> 3), with more occurrence of cardiac, infectious and surgical complications than in the controls: 39.4% <i>vs</i> 12.7% (p<0.001), 81.7% <i>vs</i> 49.3% (p<0.001), and 59.2% <i>vs</i> 40.1% (p<0.029), respectively. There were also more ICU readmissions at 1 month among HPS patients (10 <i>vs</i> 1, p=0.01). There was no significant difference concerning ventilation data, lengths of ICU or hospital stay (8.5 [range 3-232] and 32 [14-276] days, respectively on the whole cohort) and death in the ICU (4.2% on the whole cohort). The 1-year survival was higher in HPS patients (94.4% <i>vs</i> 81.1%, p=0.034); there was no difference in 5-year survival.</p><p><strong>Conclusion: </strong>HPS patients seem to have a higher number of complications in the first month following LT.</p>\",\"PeriodicalId\":14242,\"journal\":{\"name\":\"International Journal of Organ Transplantation Medicine\",\"volume\":\"11 4\",\"pages\":\"166-175\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7726840/pdf/ijotm-11-166.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Organ Transplantation Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"TRANSPLANTATION\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Organ Transplantation Medicine","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0
摘要
背景:虽然肝移植(LT)可以提高肝硬化肝肺综合征(HPS)患者的生存率,但很少有关于这些患者术后并发症的数据。目的:比较HPS患者和非HPS患者肝移植术后并发症。方法:在一项病例对照研究中,我们回顾性分析了2010年1月至2016年7月在本中心接受肝移植的所有患者。我们比较了年龄、MELD评分、合并症、红细胞输注和移植过程中灌注去甲肾上腺素的最高剂量相匹配的HPS病例和对照组。结果:在451例移植患者中,我们确定了71例可分析的HPS患者。我们发现(pvs3),心脏、感染和手术并发症的发生率比对照组高:39.4%比12.7% (pvs49.3%) (pvs40.1% (pvs1, p=0.01)。通气数据、ICU时间或住院时间(全队列分别为8.5天[范围3-232]和32天[14-276])和ICU死亡(全队列为4.2%)方面无显著差异。HPS患者的1年生存率较高(94.4% vs 81.1%, p=0.034);5年生存率无差异。结论:HPS患者在肝移植后的第一个月似乎有更多的并发症。
Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study.
Background: Although liver transplantation (LT) improves survival in cirrhotic patients with hepatopulmonary syndrome (HPS), few data exist concerning post-operative complications in these patients.
Objective: To compare complications after LT between patients with and without HPS.
Methods: In a case-control study, we retrospectively analyzed all patients who underwent LT in our center from January 2010 to July 2016. We compared cases of identified HPS to controls matched for age, MELD score, comorbidities, red blood cells transfused, and highest dosage of norepinephrine perfused during transplantation.
Results: Among 451 transplanted patients, we identified 71 patients with HPS who could be analyzed. We found a significantly (p<0.001) higher number of post-operative complications in patients with HPS (median 5 vs 3), with more occurrence of cardiac, infectious and surgical complications than in the controls: 39.4% vs 12.7% (p<0.001), 81.7% vs 49.3% (p<0.001), and 59.2% vs 40.1% (p<0.029), respectively. There were also more ICU readmissions at 1 month among HPS patients (10 vs 1, p=0.01). There was no significant difference concerning ventilation data, lengths of ICU or hospital stay (8.5 [range 3-232] and 32 [14-276] days, respectively on the whole cohort) and death in the ICU (4.2% on the whole cohort). The 1-year survival was higher in HPS patients (94.4% vs 81.1%, p=0.034); there was no difference in 5-year survival.
Conclusion: HPS patients seem to have a higher number of complications in the first month following LT.
期刊介绍:
The International Journal of Organ Transplantation Medicine (IJOTM) is a quarterly peer-reviewed English-language journal that publishes high-quality basic sciences and clinical research on transplantation. The scope of the journal includes organ and tissue donation, procurement and preservation; surgical techniques, innovations, and novelties in all aspects of transplantation; genomics and immunobiology; immunosuppressive drugs and pharmacology relevant to transplantation; graft survival and prevention of graft dysfunction and failure; clinical trials and population analyses in the field of transplantation; transplant complications; cell and tissue transplantation; infection; post-transplant malignancies; sociological and ethical issues and xenotransplantation.